Ewa Zdzislawa Raczka Wojtowicka-rekin lankidetzan egindako argitalpenak (4)

2003

  1. Age-related changes in pharmacokinetics and pharmacodynamics of lerisetron in the rat: A population pharmacokinetic model

    Gerontology, Vol. 49, Núm. 4, pp. 205-214

2002

  1. Pharmacokinetics and pharmacological effect of lerisetron, a new 5-HT3 antagonist, in rats

    Journal of Pharmaceutical Sciences, Vol. 91, Núm. 1, pp. 41-52

2001

  1. Altered disposition and effect of lerisetron in rats with elevated alpha1-acid glycoprotein levels

    Pharmaceutical Research, Vol. 18, Núm. 6, pp. 838-845

1998

  1. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer

    Cancer Chemotherapy and Pharmacology, Vol. 42, Núm. 5, pp. 418-422